Skip to main content

Wang Julia Aijun's Form 4/A amendment

Amended

BeOne Medicines Ltd. (ONC) · filed Jul 18, 2022

Accession no.
0001651308-22-000125
Filed
Jul 18, 2022
Trade date
Jul 1, 2022
Filing delay
17 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Jul 5, 2022

This filing lists 1 non-derivative transaction. Open-market sales total $50.2K. It was filed 17 days after the trade.

This amendment replaces 0001651308-22-000119 (filed Jul 5, 2022).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wang Julia AijunCIK 0001860279Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2022American Depositary SharesSSaleDisposed−317$158.50−$50,244.50Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The original Form 4, filed on July 5, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on July 1, 2022 as a total of 295 American Depositary Shares ("ADSs") sold when in fact 317 ADSs were sold. As a result of this administrative error, the number of Ordinary Shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of Ordinary Shares reported as beneficially owned by the reporting person by 286 Ordinary Shares.

F2

Each American Depositary Share represents 13 Ordinary Shares.

F3

The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 30, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read the full filing on SEC EDGAR (opens in a new tab)